Global investments into neglected disease R&D
The G-FINDER project has tracked and reported on global investments into neglected disease research and development (R&D) since 2007.
G-FINDER is a uniquely informative data source, providing policy-makers, donors, researchers and industry with objective, previously unavailable information on the state of investment, trends and patterns:
- in 39 neglected diseases and select viral haemorrhagic fevers (VHFs)
- across 142 product areas for these diseases including drugs, vaccines, diagnostics, microbicides and vector control products and
- in platform technologies (e.g. adjuvants, delivery technologies, diagnostic platforms)
The data includes all types of product-related R&D, including basic research, discovery and preclinical, clinical development, Phase IV and pharmacovigilance studies, and baseline epidemiological studies.
Funded by the Bill & Melinda Gates Foundation since inception, the G-FINDER project was originally hosted at The George Institute for International Health and then run by Policy Cures from 2010. Following the division of Policy Cures into two separate organisations in 2016, the G-FINDER project is now conducted by Policy Cures Research.